We observed that the expression of several ECM genes was significantly higher in patient-derived melanoma samples compared to the normal skin samples (Figure 5C) and a few of them are also significantly co-expressed with TP-472 target epigenetic regulator BRD7 (Figure S3). The gene discussed is BRD7; the disease is melanoma.